Global  

Common drug reduces risk of death in sickest patients

Video Credit: KTNV Channel 13 Las Vegas - Duration: 00:24s - Published
Common drug reduces risk of death in sickest patients

Common drug reduces risk of death in sickest patients

Researchers from England say they have new evidence that a drug can improve survival from COVID-19.

Surveys and tests reveal it can reduce deaths in severely ill hospitalized patients.

0
shares
ShareTweetSavePostSend
 

COVID-19.THE DRUG IS A CHEAP---WIDELYAVAILABLE STEROID CALLEDDEXAMETHASONE.RESULTS FROM A STUDY RELEASEDTODAY - SHOWS - IT REDUCEDDEATHS BY UP TO ONE THIRD INSEVERELY ILL HOSPITALIZEDPATIENTS.BUT IT DID NOT APPEAR TO HELPLESS ILL PATIENTS.THE STUDY WAS LED BY THEUNIVERSITY OF OXFORD.




You Might Like

Related news from verified sources

Early Results Show Benefit Of Steroid For Very Sick COVID-19 Patients

A low-cost anti-inflammatory drug appears to reduce the risk of death in patients with COVID-19. The...
NPR - Published


Tweets about this


Related videos from verified sources

Study Reveals The Most Common Serious Complication Following COVID-19 Recovery [Video]

Study Reveals The Most Common Serious Complication Following COVID-19 Recovery

A new study from the UK suggests patients with severe COVID-19 may be at risk for a variety of brain complications from stroke to psychosis. Of 125 patients studied, the most common brain..

Credit: Wochit     Duration: 00:35Published
Drugmaker Says Remdesivir Can Lower COVID-19 Death Risk By 62% [Video]

Drugmaker Says Remdesivir Can Lower COVID-19 Death Risk By 62%

The antiviral drug Remdesivir has proven to be effective in the treatment of COVID-19. According to UPI, the drug can lower the risk of death in COVID-19 patients by 62%. U.S. drugmaker Gilead Sciences..

Credit: Wochit Tech     Duration: 00:32Published
Gilead says remdesivir cuts death risk [Video]

Gilead says remdesivir cuts death risk

Gilead Sciences said Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19..

Credit: Reuters Studio     Duration: 01:04Published